Please assess the completion status of the following clinical trial:

Trial Title: A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients from EMR (electronic medical record) system in the primary care in Sweden~* Patients equal to or more than 18 years of age~* Starting treatment with liraglutide or sitagliptin from January 2010 to December 2013~* Minimum of 180 days of prior follow-up/history within the database before their index date~Exclusion Criteria:~* Patients with cancer, end stage liver disease, end stage renal failure (non-diabetes related)~* Female patients with gestational diabetes during pregnancy~* Patients with previous GLP-1 (glucagon-like peptide-1) or DPP-IV (dipeptidyl peptidase-4 ) inhibitor use, i.e. patients should be incretin naïve

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Liraglutide / Sitagliptin (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).